Objective: Anti-glucose-6-phosphate isomerase (GPI) antibody (Ab) is known to be arthritogenic in K/BxN mice. Anti-GPI Ab is present in some patients with rheumatoid arthritis (RA), but their clinical manifestations are not clearly elucidated. The purpose of this study was to evaluate whether GPI serves as a specific autoantigen in patients with RA and to investigate the relationship of anti-GPI Ab with clinical parameters of RA.
Antibodies to glucose-6-phosphate-isomerase (GPI) in serum of healthy controls, patients with rheumatoid arthritis (RA), and with osteoarthritis (OA) by enzyme linked immunosorbent assay (NS*: not significant).
Fig. 2.
In rheumatoid arthritis, there were no significant difference in serum anti-glucose-6-phosphate-isomerase (GPI) antibody levels according to rheumatoid factor (RF) positivity, evidence of bony erosive changes, the presence of extraarticular manifestations, and HLA-DR4 positivity. NS*: not significant, EAM**: extraarticular manifestations.
DEA solution 50μL을 첨가하여 발색반응을 시킨 후 
